Carvedilol Phosphate Capsule, Extended Release
Product Images NDC 51407-050

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol Phosphate (NDC 51407-050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407 050 30ol

51407 050 30ol
This is a description of Carvedilol Extended-Release capsules in the strength of 10 mg, packaged in a container of 30 capsules. The dosage information is available in the package insert. The capsules must be stored at a temperature between 20°C to 25°C. These capsules are different from carvedilol tablets. Caution must be taken to keep them out of reach of children and dispensed in a light-resistant container. These capsules are manufactured by Frontida Blopharm, Inc., Philadelphia, PA, and packaged by GSMS, Incorporated, Camarillo, CA.*
FDA Label Image

51407 051 30ol

51407 051 30ol
This is a medication in the form of an extended-release capsule, containing 20 mg of Carvedilol Phosphate. The package contains 30 capsules, and dosage information can be found in the package insert. The medication should be stored at 20-25°C (68-77°F). Each capsule is manufactured by Frontida Blopharm and packaged by GSMS.*
FDA Label Image

51407 052 30ol

51407 052 30ol
This is a medication package of 30 capsules of Carvedilol Phosphate at a strength of 40mg each. The medication is identified by the NDC numbers 51407-052 and 5140705230. The extended-release capsule is different in strength from Carvedilol tablets. Dosage information can be found in the package insert. The medication should be stored at 20° to 25°C (68° to 77°F). The medication must be kept out of the reach of children and dispensed in a tight, light-resistant container. The package was manufactured by Frontida Biopharm, Inc. in Philadelphia, PA 19124, and packaged by GSMS, Incorporated in Camarillo, CA 93012 USA.*
FDA Label Image

51407 053 30ol

51407 053 30ol
This is a medication in the form of extended-release capsules for once-a-day dosing. The name of the medication is Carvedilol Phosphate and it is produced by GSMS Incorporated. The NDC code for the medication is 51407-053-30. The text also includes instructions to store the medication at a controlled room temperature.*
FDA Label Image

Structure (Carvedilol 1)

FDA Label Image

Figure 5 (Carvedilol 2)

Figure 5 (Carvedilol 2)
Change in SBP and DBP readings are presented in the given text. The data is graphically represented, with the x-axis indicating the time after the morning dose in hours, and the y-axis indicating the change in blood pressure in mmHg. The lines are smoothed using a locally weighted regression smoothing methodology. No further information or context is available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.